AdvisorShares Pure US Cannabis ETF (NY:MSOS)

4.315 -0.025 (-0.58%)

Delayed Quote Updated: 12:34 PM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AdvisorShares Pure US Cannabis ETF

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call' ↗

January 03, 2025

Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.

Via Benzinga

Topics Cannabis

Here's Why Tilray Brands' CEO Is Optimistic Marijuana Legalization Will Happen Under the Trump Administration ↗

December 31, 2024

Via The Motley Fool

Topics Cannabis Government

Cannabis Reform 2024: The Year Of All Talk And No Action ↗

December 27, 2024

In 2024, the cannabis landscape in the U.S. experienced some developments, though federal legalization or removal from the CSA.

Via Benzinga

Topics Cannabis

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat? ↗

December 04, 2024

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Via Benzinga

Topics Cannabis

Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee ↗

November 21, 2024

The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.

Via Benzinga

Topics Cannabis ETFs Government

Turnaroud Tuesday: Did Canna Finally Bottom? ↗

November 12, 2024

MSOS rose over 14% in today’s session. Interestingly, the price action was inside the trading range of Monday.

Via Talk Markets

Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General ↗

November 13, 2024

Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment.

Via Benzinga

Topics Cannabis Government

Matt Gaetz Is Trump's Attorney General Pick: Would-Be Top Cop Is Under House Ethics Investigation ↗

November 13, 2024

Matt Gaetz has been named the attorney general nominee by Donald Trump. The selection comes while Gaetz is being investigated by Congress.

Via Benzinga

Topics Government

Stocks Of The Day: 4-Pillar Power Plays You Can’t Miss - Today’s Biggest Movers ↗

November 13, 2024

Markets opened with a strong tailwind, driven by the latest CPI data showing inflation in line with expectations, bolstering investor confidence.

Via Talk Markets

Topics Economy

Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis ↗

November 12, 2024

Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.

Via Benzinga

Topics Cannabis Government

The Good, The Bad, And The Ugly: A Recap Of Post-Vote Winners & Losers ↗

November 10, 2024

What’s promised on the campaign trail and what comes to reality are often different. But that didn’t stop investors and traders from speculating on the most prevalent themes under a new administration....

Via Talk Markets

Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks? ↗

November 07, 2024

After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip?

Via Benzinga

Topics Cannabis

Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close ↗

November 06, 2024

Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.

Via Benzinga

Topics Cannabis Government

Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty ↗

November 06, 2024

Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.

Via Benzinga

Topics Cannabis

Cannabis Reform Stumbles In 2024 Elections: A State-By-State Breakdown As Stocks Take A Hit ↗

November 06, 2024

Florida and the Dakotas reject cannabis measures, while Nebraska approves medical cannabis and Dallas decriminalizes. Explore each state's path forward.

Via Benzinga

Topics Cannabis

Marijuana Capital Markets: Bright 2025 Outlook Amid Regulatory Shifts ↗

November 04, 2024

Federal reform and banking access may drive cannabis capital markets in 2025. Discover why upcoming election changes could boost the industry.

Via Benzinga

Topics Cannabis

Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters ↗

October 31, 2024

Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses.

Via Benzinga

Topics Cannabis

AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest ↗

October 23, 2024

AdvisorShares MSOS ETF surges 8% as U.S. cannabis reform nears. Explore key investment signals and market opportunities.

Via Benzinga

Topics Cannabis ETFs

'The Biggest Opportunities For Investors Outside AI': Optimism Reigns At Benzinga Conference Amid Talks Of Cannabis Rescheduling, Tech Advances ↗

October 11, 2024

Cannabis leaders at the Benzinga Cannabis Capital Conference see rescheduling and banking reform as game-changers for the industry.

Via Benzinga

Topics Cannabis

EXCLUSIVE: Weed Companies Will Be Treated Like Normal Businesses Once This Tax Provision Goes Away, Experts Say ↗

October 08, 2024

Marijuana companies would be "treated like normal businesses," If the oppressive restrictions of Section 280E of the Internal Revenue Code, which prevents cannabis businesses from deducting typical...

Via Benzinga

Topics Cannabis

Profit from the Green Wave: Top Cannabis Stocks to Watch

October 02, 2024

Fueled by evolving regulations and strong market growth, the cannabis sector has emerged as a potentially lucrative long-term investment opportunity.

Via MarketBeat

Topics Cannabis

Cannabis Investor Sentiment Softens As Institutional Confidence Wanes, Survey Shows ↗

September 13, 2024

Investor sentiment on cannabis turns neutral as delays in rescheduling and uplisting affect the market. Florida legalization also analyzed...

Via Benzinga

Topics Cannabis

Will The DEA Complete Cannabis Rescheduling? Hear From Experts The Day After Harris-Trump Debate ↗

September 10, 2024

If cannabis is reclassified, the industry could see tax reforms, research opportunities, and the development of new regulatory frameworks.

Via Benzinga

Topics Cannabis

Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains ↗

September 09, 2024

Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday.

Via Benzinga

Topics Cannabis Government

Looking for the Next Big Growth Opportunity? It Might Not Be in Artificial Intelligence. ↗

September 07, 2024

Investing in cannabis could be a calculated risk worth taking right now.

Via The Motley Fool

Topics Cannabis

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit? ↗

September 05, 2024

Stocks in the cannabis sector showed varied reactions on Wednesday, after Trump's comments on the legalization of marijuana in Florida.

Via Benzinga

Topics Cannabis Government

Cheaper Than A Big Mac: Weed Penny Stocks Emerge As Winners Amidst Market Downturn ↗

August 29, 2024

Amidst the market backdrop, a few cannabis penny stocks, priced lower than one of McDonald's (NYSE: MCD) classics, have shown resilience.

Via Benzinga

Topics Cannabis

Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris ↗

August 28, 2024

Congressman Earl Blumenauer, a Democrat from Oregon and co-chair of the Congressional Cannabis Caucus is disappointed the U.S. Drug Enforcement Administration (DEA) opted to delay rescheduling of...

Via Benzinga

Topics Cannabis

Cannabis Stocks Plummet By Up To 16% On DEA Rescheduling Delay: Could This Be The Buying Opportunity Of 2024? ↗

August 27, 2024

The market's response was immediate and pronounced. Cannabis stocks plummeted, with MOSOS ETF dropping over 10% in early trading.

Via Benzinga

Topics Cannabis ETFs

Key Cannabis Leaders Gather For Networking At Benzinga's Fall 2024 Conference: The Last Big Event Before The Election ↗

August 26, 2024

Join cannabis industry leaders at Benzinga's Fall Conference in Chicago. Keynotes, networking, and legalization insights.

Via Benzinga

Topics Cannabis

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.